4-(2-Aminophenoxy)-N-methylpicolinamide

Catalog No. :
ACGQBY582
CAS No. :
1153328-25-6
Molecular Formula :
C13H13N3O2
Molecular Weight :
243.27

IUPAC Name:4-(2-aminophenoxy)-N-methylpicolinamide

4-(2-Aminophenoxy)-N-methylpicolinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$243.00Login to see priceInquiryInquiry
100mg97%$354.00Login to see priceInquiryInquiry
250mg97%$498.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Aminophenoxy)-N-methylpicolinamide
IUPAC Name4-(2-aminophenoxy)-N-methylpicolinamide
MDL No.MFCD12424734
Molecular FormulaC13H13N3O2
Molecular Weight243.27
SMILESO=C(NC)C1=NC=CC(OC2=CC=CC=C2N)=C1
InChI KeySPPHZSPCIPWKOV-UHFFFAOYSA-N
SynonymPirfenidone Impurity 1;Sorafenib Impurity 37;Sorafenib Impurity HC121-201812;Regorafenib Impurity ZW;2-Pyridinecarboxamide, 4-(2-aminophenoxy)-N-methyl-;4-(2-Aminophenoxy)-N-methylpyridine-2-carboxamide;4-(2-aminophenoxy)-N-methylpicolinamide? (Regorafenib Impurity);4-(2-Aminophenoxy)-N-methylpicolinamide
CAS No.1153328-25-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGQBY582 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIAGD894 route compound structure diagram
    ACIAGD894220000-87-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGQBY582 route product structure diagram
    ACGQBY5821153328-25-6
Inquiry

2. ACGQBY582 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGQBY582 route product structure diagram
    ACGQBY5821153328-25-6
Inquiry

Comments (0)